ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma

NCT01592045 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: ch14.18 -NCI
BIOLOGICAL: ch14.18-UTC
BIOLOGICAL: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
BIOLOGICAL: Aldesleukin (IL-2)
DRUG: Isotretinoin

Sponsor

United Therapeutics